Pantoea calida bacteremia in an adult with end-stage stomach cancer under inpatient care

Abstract Pantoea calida is a gram-negative bacillus that was first identified in 2010. Here, we describe the first known case of P. calida bacteremia in a 77-year-old woman with end-stage stomach cancer under inpatient care. The patient was admitted to our hospital for pain after receiving anti-canc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2017-06, Vol.23 (6), p.407-409
Hauptverfasser: Yamada, Kageto, Kashiwa, Machiko, Arai, Katsumi, Satoyoshi, Kazuya, Nishiyama, Hiroyuki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 409
container_issue 6
container_start_page 407
container_title Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
container_volume 23
creator Yamada, Kageto
Kashiwa, Machiko
Arai, Katsumi
Satoyoshi, Kazuya
Nishiyama, Hiroyuki
description Abstract Pantoea calida is a gram-negative bacillus that was first identified in 2010. Here, we describe the first known case of P. calida bacteremia in a 77-year-old woman with end-stage stomach cancer under inpatient care. The patient was admitted to our hospital for pain after receiving anti-cancer therapy at outpatient facility. Thirteen days after admission, her temperature rose to 39.6 °C. A blood culture was ordered for suspected bacterial infection, and the patient was treated empirically with ampicillin/sulbactam. Cultures showed white pitting colonies later identified as a Pantoea sp. by biochemical analysis. The isolate’s 16S rRNA sequence was identical to that of P. calida (100%), and showed 99.1% similarity with that of Pantoea gaviniae . Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) confirmed the species as P. calida with an average spectral score > 2.0. The primary isolate was ampicillin-resistant, but susceptible to other antibiotics and the bacteremia was cleared after three days of antibiotic therapy. Since P. calida infection is relatively rare, limited information exists on the pathogen’s portal of entry and bacterial characteristics; thus, further studies are necessary to establish the pathophysiological mechanisms P. calida infection.
doi_str_mv 10.1016/j.jiac.2017.01.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1865519350</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1341321X17300144</els_id><sourcerecordid>1865519350</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-83140ac58afbdac38538531ddcaa592c9656c57c3d7085905c4fcac7290abcff3</originalsourceid><addsrcrecordid>eNp9kV-L1TAQxYso7rr6BXyQPvrSmmmaNgURZPEfLCiosG9h7mTqprbpNUmV_fam3NUHH4QhCeGcA_M7RfEURA0CuhdTPTmkuhHQ1wJqIeBecQ6t7Ku-1-J-fssWKtnA9VnxKMYpC3ql9cPirNHQQTO058X1J_RpZSwJZ2exPCAlDrw4LJ0vMY_d5lT-cummZG-rmPAblzGtC9JNNnniUG7e5tP5IybHPuXvwI-LByPOkZ_c3RfF17dvvly-r64-vvtw-fqqolaqVGkJrUBSGseDRZJa7QPWEqIaGho61ZHqSdpeaDUIRe1ISH0zCDzQOMqL4vkp9xjWHxvHZBYXiecZPa9bNKA7pWCQSmRpc5JSWGMMPJpjcAuGWwPC7ETNZHaiZidqBJgMLJue3eVvh4XtX8sfhFnw8iTgvOVPx8FEyhSIrQtMydjV_T__1T92mp13uY7vfMtxWrfgMz8DJjZGmM97p3ul0Mtsb1v5G5fMnGY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1865519350</pqid></control><display><type>article</type><title>Pantoea calida bacteremia in an adult with end-stage stomach cancer under inpatient care</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Yamada, Kageto ; Kashiwa, Machiko ; Arai, Katsumi ; Satoyoshi, Kazuya ; Nishiyama, Hiroyuki</creator><creatorcontrib>Yamada, Kageto ; Kashiwa, Machiko ; Arai, Katsumi ; Satoyoshi, Kazuya ; Nishiyama, Hiroyuki</creatorcontrib><description>Abstract Pantoea calida is a gram-negative bacillus that was first identified in 2010. Here, we describe the first known case of P. calida bacteremia in a 77-year-old woman with end-stage stomach cancer under inpatient care. The patient was admitted to our hospital for pain after receiving anti-cancer therapy at outpatient facility. Thirteen days after admission, her temperature rose to 39.6 °C. A blood culture was ordered for suspected bacterial infection, and the patient was treated empirically with ampicillin/sulbactam. Cultures showed white pitting colonies later identified as a Pantoea sp. by biochemical analysis. The isolate’s 16S rRNA sequence was identical to that of P. calida (100%), and showed 99.1% similarity with that of Pantoea gaviniae . Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) confirmed the species as P. calida with an average spectral score &gt; 2.0. The primary isolate was ampicillin-resistant, but susceptible to other antibiotics and the bacteremia was cleared after three days of antibiotic therapy. Since P. calida infection is relatively rare, limited information exists on the pathogen’s portal of entry and bacterial characteristics; thus, further studies are necessary to establish the pathophysiological mechanisms P. calida infection.</description><identifier>ISSN: 1341-321X</identifier><identifier>EISSN: 1437-7780</identifier><identifier>DOI: 10.1016/j.jiac.2017.01.001</identifier><identifier>PMID: 28161294</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Aged ; Ampicillin - pharmacology ; Ampicillin - therapeutic use ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Bacteremia ; Bacteremia - complications ; Bacteremia - diagnosis ; Bacteremia - microbiology ; Cancer ; Enterobacteriaceae Infections - complications ; Enterobacteriaceae Infections - diagnosis ; Enterobacteriaceae Infections - microbiology ; Female ; Hematology, Oncology and Palliative Medicine ; Hospitalization ; Humans ; Microbial Sensitivity Tests ; Pantoea - chemistry ; Pantoea - drug effects ; Pantoea - isolation &amp; purification ; Pantoea calida ; Stomach Neoplasms - complications ; Sulbactam - pharmacology ; Sulbactam - therapeutic use</subject><ispartof>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017-06, Vol.23 (6), p.407-409</ispartof><rights>Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases</rights><rights>2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases</rights><rights>Copyright © 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-83140ac58afbdac38538531ddcaa592c9656c57c3d7085905c4fcac7290abcff3</citedby><cites>FETCH-LOGICAL-c435t-83140ac58afbdac38538531ddcaa592c9656c57c3d7085905c4fcac7290abcff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28161294$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamada, Kageto</creatorcontrib><creatorcontrib>Kashiwa, Machiko</creatorcontrib><creatorcontrib>Arai, Katsumi</creatorcontrib><creatorcontrib>Satoyoshi, Kazuya</creatorcontrib><creatorcontrib>Nishiyama, Hiroyuki</creatorcontrib><title>Pantoea calida bacteremia in an adult with end-stage stomach cancer under inpatient care</title><title>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</title><addtitle>J Infect Chemother</addtitle><description>Abstract Pantoea calida is a gram-negative bacillus that was first identified in 2010. Here, we describe the first known case of P. calida bacteremia in a 77-year-old woman with end-stage stomach cancer under inpatient care. The patient was admitted to our hospital for pain after receiving anti-cancer therapy at outpatient facility. Thirteen days after admission, her temperature rose to 39.6 °C. A blood culture was ordered for suspected bacterial infection, and the patient was treated empirically with ampicillin/sulbactam. Cultures showed white pitting colonies later identified as a Pantoea sp. by biochemical analysis. The isolate’s 16S rRNA sequence was identical to that of P. calida (100%), and showed 99.1% similarity with that of Pantoea gaviniae . Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) confirmed the species as P. calida with an average spectral score &gt; 2.0. The primary isolate was ampicillin-resistant, but susceptible to other antibiotics and the bacteremia was cleared after three days of antibiotic therapy. Since P. calida infection is relatively rare, limited information exists on the pathogen’s portal of entry and bacterial characteristics; thus, further studies are necessary to establish the pathophysiological mechanisms P. calida infection.</description><subject>Aged</subject><subject>Ampicillin - pharmacology</subject><subject>Ampicillin - therapeutic use</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacteremia</subject><subject>Bacteremia - complications</subject><subject>Bacteremia - diagnosis</subject><subject>Bacteremia - microbiology</subject><subject>Cancer</subject><subject>Enterobacteriaceae Infections - complications</subject><subject>Enterobacteriaceae Infections - diagnosis</subject><subject>Enterobacteriaceae Infections - microbiology</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Microbial Sensitivity Tests</subject><subject>Pantoea - chemistry</subject><subject>Pantoea - drug effects</subject><subject>Pantoea - isolation &amp; purification</subject><subject>Pantoea calida</subject><subject>Stomach Neoplasms - complications</subject><subject>Sulbactam - pharmacology</subject><subject>Sulbactam - therapeutic use</subject><issn>1341-321X</issn><issn>1437-7780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV-L1TAQxYso7rr6BXyQPvrSmmmaNgURZPEfLCiosG9h7mTqprbpNUmV_fam3NUHH4QhCeGcA_M7RfEURA0CuhdTPTmkuhHQ1wJqIeBecQ6t7Ku-1-J-fssWKtnA9VnxKMYpC3ql9cPirNHQQTO058X1J_RpZSwJZ2exPCAlDrw4LJ0vMY_d5lT-cummZG-rmPAblzGtC9JNNnniUG7e5tP5IybHPuXvwI-LByPOkZ_c3RfF17dvvly-r64-vvtw-fqqolaqVGkJrUBSGseDRZJa7QPWEqIaGho61ZHqSdpeaDUIRe1ISH0zCDzQOMqL4vkp9xjWHxvHZBYXiecZPa9bNKA7pWCQSmRpc5JSWGMMPJpjcAuGWwPC7ETNZHaiZidqBJgMLJue3eVvh4XtX8sfhFnw8iTgvOVPx8FEyhSIrQtMydjV_T__1T92mp13uY7vfMtxWrfgMz8DJjZGmM97p3ul0Mtsb1v5G5fMnGY</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Yamada, Kageto</creator><creator>Kashiwa, Machiko</creator><creator>Arai, Katsumi</creator><creator>Satoyoshi, Kazuya</creator><creator>Nishiyama, Hiroyuki</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>Pantoea calida bacteremia in an adult with end-stage stomach cancer under inpatient care</title><author>Yamada, Kageto ; Kashiwa, Machiko ; Arai, Katsumi ; Satoyoshi, Kazuya ; Nishiyama, Hiroyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-83140ac58afbdac38538531ddcaa592c9656c57c3d7085905c4fcac7290abcff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Ampicillin - pharmacology</topic><topic>Ampicillin - therapeutic use</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacteremia</topic><topic>Bacteremia - complications</topic><topic>Bacteremia - diagnosis</topic><topic>Bacteremia - microbiology</topic><topic>Cancer</topic><topic>Enterobacteriaceae Infections - complications</topic><topic>Enterobacteriaceae Infections - diagnosis</topic><topic>Enterobacteriaceae Infections - microbiology</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Microbial Sensitivity Tests</topic><topic>Pantoea - chemistry</topic><topic>Pantoea - drug effects</topic><topic>Pantoea - isolation &amp; purification</topic><topic>Pantoea calida</topic><topic>Stomach Neoplasms - complications</topic><topic>Sulbactam - pharmacology</topic><topic>Sulbactam - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Kageto</creatorcontrib><creatorcontrib>Kashiwa, Machiko</creatorcontrib><creatorcontrib>Arai, Katsumi</creatorcontrib><creatorcontrib>Satoyoshi, Kazuya</creatorcontrib><creatorcontrib>Nishiyama, Hiroyuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Kageto</au><au>Kashiwa, Machiko</au><au>Arai, Katsumi</au><au>Satoyoshi, Kazuya</au><au>Nishiyama, Hiroyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pantoea calida bacteremia in an adult with end-stage stomach cancer under inpatient care</atitle><jtitle>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</jtitle><addtitle>J Infect Chemother</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>23</volume><issue>6</issue><spage>407</spage><epage>409</epage><pages>407-409</pages><issn>1341-321X</issn><eissn>1437-7780</eissn><abstract>Abstract Pantoea calida is a gram-negative bacillus that was first identified in 2010. Here, we describe the first known case of P. calida bacteremia in a 77-year-old woman with end-stage stomach cancer under inpatient care. The patient was admitted to our hospital for pain after receiving anti-cancer therapy at outpatient facility. Thirteen days after admission, her temperature rose to 39.6 °C. A blood culture was ordered for suspected bacterial infection, and the patient was treated empirically with ampicillin/sulbactam. Cultures showed white pitting colonies later identified as a Pantoea sp. by biochemical analysis. The isolate’s 16S rRNA sequence was identical to that of P. calida (100%), and showed 99.1% similarity with that of Pantoea gaviniae . Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) confirmed the species as P. calida with an average spectral score &gt; 2.0. The primary isolate was ampicillin-resistant, but susceptible to other antibiotics and the bacteremia was cleared after three days of antibiotic therapy. Since P. calida infection is relatively rare, limited information exists on the pathogen’s portal of entry and bacterial characteristics; thus, further studies are necessary to establish the pathophysiological mechanisms P. calida infection.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>28161294</pmid><doi>10.1016/j.jiac.2017.01.001</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1341-321X
ispartof Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017-06, Vol.23 (6), p.407-409
issn 1341-321X
1437-7780
language eng
recordid cdi_proquest_miscellaneous_1865519350
source MEDLINE; Alma/SFX Local Collection
subjects Aged
Ampicillin - pharmacology
Ampicillin - therapeutic use
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Bacteremia
Bacteremia - complications
Bacteremia - diagnosis
Bacteremia - microbiology
Cancer
Enterobacteriaceae Infections - complications
Enterobacteriaceae Infections - diagnosis
Enterobacteriaceae Infections - microbiology
Female
Hematology, Oncology and Palliative Medicine
Hospitalization
Humans
Microbial Sensitivity Tests
Pantoea - chemistry
Pantoea - drug effects
Pantoea - isolation & purification
Pantoea calida
Stomach Neoplasms - complications
Sulbactam - pharmacology
Sulbactam - therapeutic use
title Pantoea calida bacteremia in an adult with end-stage stomach cancer under inpatient care
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T16%3A20%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pantoea%20calida%20bacteremia%20in%20an%20adult%20with%20end-stage%20stomach%20cancer%20under%20inpatient%20care&rft.jtitle=Journal%20of%20infection%20and%20chemotherapy%20:%20official%20journal%20of%20the%20Japan%20Society%20of%20Chemotherapy&rft.au=Yamada,%20Kageto&rft.date=2017-06-01&rft.volume=23&rft.issue=6&rft.spage=407&rft.epage=409&rft.pages=407-409&rft.issn=1341-321X&rft.eissn=1437-7780&rft_id=info:doi/10.1016/j.jiac.2017.01.001&rft_dat=%3Cproquest_cross%3E1865519350%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1865519350&rft_id=info:pmid/28161294&rft_els_id=1_s2_0_S1341321X17300144&rfr_iscdi=true